E M Rubin

1.1k total citations
6 papers, 943 citations indexed

About

E M Rubin is a scholar working on Molecular Biology, Surgery and Cellular and Molecular Neuroscience. According to data from OpenAlex, E M Rubin has authored 6 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in E M Rubin's work include Lipoproteins and Cardiovascular Health (3 papers), Genetics, Bioinformatics, and Biomedical Research (3 papers) and Animal Genetics and Reproduction (3 papers). E M Rubin is often cited by papers focused on Lipoproteins and Cardiovascular Health (3 papers), Genetics, Bioinformatics, and Biomedical Research (3 papers) and Animal Genetics and Reproduction (3 papers). E M Rubin collaborates with scholars based in United States and United Kingdom. E M Rubin's co-authors include Nobuo Maeda, Richard M. Lawn, Brian Y. Ishida, S Clift, Ronald M. Krauss, Matthew J. Callow, Judy G. Verstuyft, Xing Jian Lou, Karen Schwartz and S. Hughes and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Lipid Research.

In The Last Decade

E M Rubin

6 papers receiving 925 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E M Rubin United States 6 556 370 325 203 135 6 943
Glenda D. Talley United States 14 753 1.4× 394 1.1× 514 1.6× 250 1.2× 99 0.7× 19 1.2k
T Mazzone United States 21 575 1.0× 479 1.3× 295 0.9× 228 1.1× 274 2.0× 31 1.2k
Dale Newland United States 10 543 1.0× 425 1.1× 177 0.5× 184 0.9× 350 2.6× 14 1.2k
Nobuo Sekine Japan 15 440 0.8× 488 1.3× 298 0.9× 89 0.4× 83 0.6× 19 1.0k
E. de Wit Netherlands 16 297 0.5× 347 0.9× 240 0.7× 164 0.8× 111 0.8× 26 771
Junichiro Tohyama United States 14 381 0.7× 240 0.6× 245 0.8× 166 0.8× 145 1.1× 17 790
Shozo Kobori Japan 15 332 0.6× 266 0.7× 175 0.5× 143 0.7× 250 1.9× 36 863
Ayce Yesilaltay United States 18 409 0.7× 503 1.4× 95 0.3× 130 0.6× 157 1.2× 20 1.0k
M Antonucci France 9 392 0.7× 986 2.7× 172 0.5× 293 1.4× 263 1.9× 21 1.4k
John A. Krawiec United States 9 222 0.4× 469 1.3× 323 1.0× 88 0.4× 72 0.5× 10 924

Countries citing papers authored by E M Rubin

Since Specialization
Citations

This map shows the geographic impact of E M Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E M Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E M Rubin more than expected).

Fields of papers citing papers by E M Rubin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E M Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E M Rubin. The network helps show where E M Rubin may publish in the future.

Co-authorship network of co-authors of E M Rubin

This figure shows the co-authorship network connecting the top 25 collaborators of E M Rubin. A scholar is included among the top collaborators of E M Rubin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E M Rubin. E M Rubin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Lou, Xing Jian, et al.. (1997). Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice.. Journal of Clinical Investigation. 100(3). 558–564. 76 indexed citations
2.
Morrison, John R., et al.. (1996). Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism.. Proceedings of the National Academy of Sciences. 93(14). 7154–7159. 67 indexed citations
3.
Maeda, Nobuo, et al.. (1994). Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice.. Journal of Clinical Investigation. 94(2). 899–903. 322 indexed citations
4.
Callow, Matthew J., et al.. (1994). Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice.. Proceedings of the National Academy of Sciences. 91(6). 2130–2134. 143 indexed citations
5.
Lawn, Richard M., et al.. (1994). Human apolipoprotein A-I prevents atherosclerosis associated with apolipoprotein[a] in transgenic mice.. Journal of Lipid Research. 35(12). 2263–2267. 93 indexed citations
6.
Rubin, E M, Brian Y. Ishida, S Clift, & Ronald M. Krauss. (1991). Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses.. Proceedings of the National Academy of Sciences. 88(2). 434–438. 242 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026